(DNLI) Denali Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Denali Therapeutics | (DNLI) share price targets
Complete technical analysis of Denali Therapeutics (DNLI) by charts plus indicators, forecast predictions and share price targets for Denali Therapeutics (DNLI)
Denali Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-11-05 View latest technical analysis
10 day averaged volume of Denali Therapeutics is 682990
Date | Daily Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 27.65 | 26.17 | 27.70 | 26.17 | 0.815 times |
04 Mon Nov 2024 | 27.21 | 26.91 | 27.63 | 26.76 | 0.889 times |
01 Fri Nov 2024 | 27.05 | 26.65 | 27.49 | 26.27 | 1.227 times |
31 Thu Oct 2024 | 25.96 | 26.64 | 26.74 | 25.55 | 0.816 times |
30 Wed Oct 2024 | 26.85 | 27.22 | 27.64 | 26.83 | 0.844 times |
29 Tue Oct 2024 | 27.47 | 27.64 | 27.74 | 26.98 | 2.571 times |
28 Mon Oct 2024 | 27.78 | 26.50 | 27.80 | 26.23 | 1.186 times |
25 Fri Oct 2024 | 26.15 | 26.54 | 27.00 | 26.04 | 0.6 times |
24 Thu Oct 2024 | 26.44 | 26.31 | 26.60 | 26.01 | 0.75 times |
23 Wed Oct 2024 | 26.08 | 26.12 | 26.47 | 25.85 | 0.543 times |
My analysis of stock is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if stock stays above 27.6, but if it comes below 27.6, then a intra day sell could be more profitable.
If you take a sell trade below 27.6, then use 27.6 as stoploss and 26.9 as target. However if you take a buy trade in stock , then use 27.6 as stoploss and 28.4 as target.
Share price targets for Denali Therapeutics (DNLI)
Target Type | Value |
Downside Target | 19.74 |
Downside Target | 20.43 |
Downside Target | 24.24 |
Downside Target | 25.24 |
Downside Target | 27.49 |
Upside Target | 27.70 |
Upside Target | 27.80 |
Upside Target | 28.00 |
Upside Target | 28.07 |
Upside Target | 29.67 |
Upside Target | 32.13 |
Intraday share price targets for Denali Therapeutics (DNLI)
Target Type | Value |
Downside Intraday Target | 26.65 |
Downside Intraday Target | 25.64 |
Upside Intraday Target | 28.18 |
Upside Intraday Target | 28.7 |
Downside Intraday Target | 27.17 |
Weekly technical analysis of Denali Therapeutics (DNLI)
Date | Weekly Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 27.65 | 26.91 | 27.70 | 26.17 | 0.256 times |
01 Fri Nov 2024 | 27.05 | 26.50 | 27.80 | 25.55 | 2.088 times |
25 Fri Oct 2024 | 26.15 | 27.36 | 27.49 | 25.85 | 0.677 times |
18 Fri Oct 2024 | 27.59 | 27.90 | 28.00 | 26.49 | 0.851 times |
11 Fri Oct 2024 | 28.00 | 27.89 | 28.07 | 25.28 | 1.321 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Denali Therapeutics (DNLI)
Date | Monthly Closing Price | Open | High | Low | Volume |
05 Tue Nov 2024 | 27.65 | 26.65 | 27.70 | 26.17 | 0.133 times |
31 Thu Oct 2024 | 25.96 | 29.18 | 29.67 | 25.28 | 0.687 times |
30 Mon Sep 2024 | 29.13 | 24.36 | 32.13 | 24.24 | 1.097 times |
30 Fri Aug 2024 | 24.44 | 23.80 | 25.90 | 19.74 | 0.881 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Denali Therapeutics (DNLI)
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Denali Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Denali Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Denali Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Denali Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 27.05 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Denali Therapeutics ( (DNLI) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Denali Therapeutics stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Denali Therapeutics in short term and the buy signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Denali Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Denali Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Denali Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 27.05 and Denali Therapeutics (DNLI) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Denali Therapeutics (DNLI) stock. Volume based technical analysis of Denali Therapeutics (DNLI) stock is negative.
Denali Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.